Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma.
J Gastrointest Oncol. 2020 Feb;11(1):61-67. doi: 10.21037/jgo.2019.11.06.
J Gastrointest Oncol. 2020.
PMID: 32175106
Free PMC article.
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies.
Lim KH, Opyrchal M, Acharya A, Boice N, Wu N, Gao F, Webster J, Lockhart AC, Waqar SN, Govindan R, Morgensztern D, Picus J, Tan BR, Baggstrom MQ, Maher CA, Wang-Gillam A.
Lim KH, et al. Among authors: boice n.
Eur J Cancer. 2021 Sep;154:102-110. doi: 10.1016/j.ejca.2021.06.012. Epub 2021 Jul 10.
Eur J Cancer. 2021.
PMID: 34256279
Clinical Trial.
Item in Clipboard
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.
Wang-Gillam A, Lim KH, McWilliams R, Suresh R, Lockhart AC, Brown A, Breden M, Belle JI, Herndon J, Bogner SJ, Pedersen K, Tan B, Boice N, Acharya A, Abdiannia M, Gao F, Yoon HH, Zhu M, Trikalinos NA, Ratner L, Aranha O, Hawkins WG, Herzog BH, DeNardo DG.
Wang-Gillam A, et al. Among authors: boice n.
Clin Cancer Res. 2022 Dec 15;28(24):5254-5262. doi: 10.1158/1078-0432.CCR-22-0308.
Clin Cancer Res. 2022.
PMID: 36228156
Free PMC article.
Clinical Trial.
Item in Clipboard
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy.
Grierson PM, Suresh R, Tan B, Pedersen KS, Amin M, Park H, Trikalinos NA, Liu J, Boice N, Brown A, Bansod S, Wang-Gillam A, Lim KH.
Grierson PM, et al. Among authors: boice n.
Clin Cancer Res. 2023 Dec 1;29(23):4733-4739. doi: 10.1158/1078-0432.CCR-23-1405.
Clin Cancer Res. 2023.
PMID: 37801295
Item in Clipboard
Correction: Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: a Phase I Dose Escalation and Expansion Study.
Wang-Gillam A, Lim KH, McWilliams R, Suresh R, Lockhart AC, Brown A, Breden M, Belle JI, Herndon J, Bogner SJ, Pedersen K, Tan B, Boice N, Acharya A, Abdiannia M, Gao F, Yoon HH, Zhu M, Trikalinos NA, Ratner L, Aranha O, Hawkins WG, Herzog BH, DeNardo DG.
Wang-Gillam A, et al. Among authors: boice n.
Clin Cancer Res. 2023 Nov 14;29(22):4698. doi: 10.1158/1078-0432.CCR-23-2993.
Clin Cancer Res. 2023.
PMID: 37960920
No abstract available.
Item in Clipboard
Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases.
Stein S, Bogard E, Boice N, Fernandez V, Field T, Gilstrap A, Kahn SR, Larkindale J, Mathieson T.
Stein S, et al. Among authors: boice n.
Orphanet J Rare Dis. 2018 Jan 22;13(1):18. doi: 10.1186/s13023-018-0761-2.
Orphanet J Rare Dis. 2018.
PMID: 29357903
Free PMC article.
Item in Clipboard
Cite
Cite